Arteris (AIP) CEO Sells $654k in Stock Under 10b5-1 Plan
Arteris, Inc.
Subscribe to track AIP
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Arteris CEO Sells $654k in Stock
Company: Arteris, Inc. (AIP) Form: 4 | Filed: 2025-10-10 Significance: Medium
Insider: JANAC K CHARLES Title: President and CEO | Relationship: Director, Officer, 10% Owner
Transaction: • Type: Sale • Shares: 50,000 • Price: $13.07 • Value: $653,710 • Owned After (Indirectly via LLC): 9,689,071
Key Insight: This sale was executed under a pre-scheduled 10b5-1 trading plan adopted in March 2025, which typically reduces the immediate negative signal of an insider sale.
Market Context: A significant sale by a top executive, though planned in advance. The insider still holds a substantial position in the company across various direct and indirect accounts.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: Arteris, Inc. (AIP)
Executive Summary
- Trading Significance: Medium
- Key Takeaway: K. Charles Janac, the President, CEO, Director, and a 10%+ owner of Arteris, Inc., sold 50,000 shares for a total value of approximately $654,000. The transaction was conducted under a pre-arranged 10b5-1 trading plan, which mitigates the negative sentiment typically associated with insider sales.
- Market Impact: The market impact is expected to be neutral to slightly negative. While a CEO sale is notable, its execution under a 10b5-1 plan suggests it was for personal financial planning rather than a reaction to near-term company prospects.
Company Information
| Field | Value |
|---|---|
| Company | Arteris, Inc. |
| Ticker Symbol | AIP |
| CIK | 0001667011 |
| Industry | SEMICONDUCTORS & RELATED DEVICES [3674] |
Insider Information
| Field | Value |
|---|---|
| Name | JANAC K CHARLES |
| CIK | 0001068987 |
| Title/Position | President and CEO |
| Relationship | Director, Officer, 10% Owner |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-10-08 |
| Transaction Code | S (Sale) |
| Security Type | Common Stock |
| Shares Involved | 50,000 |
| Price Per Share | $13.0742 (Weighted Average) |
| Total Value | $653,710 |
| Shares Owned After | 9,689,071 (in this specific indirect account) |
| Ownership Type | Indirect (via Bayview Legacy, LLC) |
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The sale by a top executive is significant. However, the explicit mention of a 10b5-1 trading plan adopted months prior (March 5, 2025) indicates that this was a pre-scheduled transaction. Such plans are used by insiders to sell shares over time for liquidity and diversification, and are not typically based on immediate, non-public information. Therefore, the market is likely to discount the negative signal of the sale.
Volume & Sentiment
- Expected Volume Impact: Minimal to low. The news may generate some discussion, but it is unlikely to cause a major shift in trading volume.
- Sentiment Indicator: Neutral. The status of the insider (CEO) is a bearish factor, but the 10b5-1 plan context neutralizes it.
Investment Insights
Positive Market Indicators
- The insider continues to hold a very large position in the company post-transaction (over 9.8 million shares across direct and indirect holdings), indicating continued significant alignment with shareholder interests.
Risk Factors
- A sale by a CEO, even if planned, can sometimes be perceived negatively by retail investors who may not understand the nuances of 10b5-1 plans.
- The sale represents a reduction, albeit small, in the CEO's holdings.
Key Takeaways
- Pre-Planned Sale: The most critical piece of context is the 10b5-1 plan, which makes this a routine liquidity event rather than a reactive trade.
- Substantial Remaining Stake: The CEO's remaining ownership is substantial, demonstrating a long-term vested interest in the company's success.
- C-Suite Transaction: All transactions by a CEO are closely watched. This sale provides a data point on the executive's financial activities but is not a strong indicator of future company performance on its own.
Contextual Analysis
Timing Significance
The sale occurred in early October. The 10b5-1 plan was established in March, suggesting the timing is part of a long-term, systematic selling schedule rather than a response to current market conditions or recent company performance.
Transaction Context
According to Footnote 1, the sale was made pursuant to a 10b5-1 plan. Footnote 2 clarifies the reported price is a weighted average, with sales occurring between $13.00 and $13.20. The sale was conducted indirectly through Bayview Legacy, LLC, which the reporting person manages.
Company Context
This analysis is based solely on the filing. A full picture would require reviewing Arteris, Inc.'s recent earnings reports, press releases, and overall performance within the semiconductor industry to understand the broader environment in which this transaction occurred.
Risk Assessment
Risk Level: Low
Risk Factors
- Perception Risk: Investors may misinterpret the sale as a lack of confidence if they overlook the 10b5-1 plan context.
- Concentration Risk: The insider remains a 10%+ owner, and future sales, even if planned, could create downward pressure on the stock price over time.
Market Considerations
- Sector Trends: The performance of the semiconductor sector can have a greater impact on the stock price than this individual insider transaction.
- Automated Trading: Algorithmic trading systems may react negatively to the headline 'CEO Sale' before human analysis can factor in the 10b5-1 plan.
IMPORTANT DISCLAIMER: This analysis is for informational purposes only and is not intended as investment advice. The information presented is based on publicly available SEC filings and should not be construed as a recommendation to buy, sell, or hold any securities. Past performance does not guarantee future results. All investments carry risk, including the potential loss of principal. Please consult with a qualified financial advisor before making any investment decisions.
Analysis generated on 2025-10-10 | Data source: SEC EDGAR
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
